Where can I find TLOG's financial statements?

TetraLogic Pharmaceuticals Corporation (TLOG)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for TLOG?

TetraLogic Pharmaceuticals Corporation (TLOG) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does TLOG update its statements?

TetraLogic Pharmaceuticals Corporation files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

TLOG

TetraLogic Pharmaceuticals Corporation

OTC·Biotechnology · Healthcare

$0.00$0.00+0.00%

Market cap$979.00·Market closed·Aug 25 8:00 PM UTC

USD · values shown as reported

Line item	FY 2011	FY 2012	FY 2013	FY 2014	FY 2015	Trend
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Cost of revenue	—	—	—	—	$187.99K	—
Gross profit	$0.00	$0.00	$0.00	$0.00	−$187.99K
Research & development	$15.25M	$12.10M−20.7%	$9.52M−21.3%	$20.29M+113.0%	$27.40M+35.1%
General & administrative	—	$4.08M	$8.47M+107.8%	$10.93M+29.0%	$11.10M+1.6%
SG&A (combined)	$3.62M	$4.08M+12.7%	$8.47M+107.8%	$10.93M+29.0%	$11.10M+1.6%
Total operating expenses	$18.87M	$16.17M−14.3%	$17.99M+11.2%	$31.21M+73.5%	$38.50M+23.3%
Operating income	−$18.87M	−$16.17M+14.3%	−$17.99M−11.2%	−$33.79M−87.8%	−$44.99M−33.2%
Interest income	$4.90K	$2.69K−45.0%	$629.00−76.7%	$112.82K+17,835.6%	$99.61K−11.7%
Interest expense	$6.75K	$73.35K+986.2%	$2.77M+3,672.7%	$3.36M+21.4%	$6.38M+90.0%
Other income / (expense), net	−$50.31K	−$27.52K+45.3%	−$1.96M−7,019.8%	−$4.75M−142.2%	−$11.22M−136.5%
Income before tax	−$18.92M	−$16.20M+14.4%	−$19.95M−23.2%	−$35.96M−80.2%	−$49.72M−38.3%
Income tax expense	$6.75K	$73.35K+986.2%	$2.77M+3,672.7%	$3.36M+21.4%	$6.38M+90.0%
Net income	−$18.93M	−$16.27M+14.0%	−$22.72M−39.6%	−$39.32M−73.1%	−$56.11M−42.7%

EPS (basic)	−$14.80	−$16.78−13.4%	−$9.90+41.0%	−$1.76+82.2%	−$2.37−34.7%
EPS (diluted)	−$14.80	−$16.78−13.4%	−$9.90+41.0%	−$1.76+82.2%	−$2.36−34.1%
Weighted avg shares (basic)	1,278,400	969,998	2,295,636	22,290,069	23,692,327
Weighted avg shares (diluted)	1,278,400	969,998	2,295,636	22,351,689	23,730,375

Depreciation & amortization	$219.74K	$156.72K−28.7%	$100.22K−36.1%	$2.81M+2,704.6%	$6.78M+141.2%
EBITDA	−$18.70M	−$15.97M+14.6%	−$17.08M−7.0%	−$32.47M−90.1%	−$43.15M−32.9%

Frequently Asked Questions About TLOG

Where can I find TLOG's financial statements?: TetraLogic Pharmaceuticals Corporation (TLOG)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for TLOG?: TetraLogic Pharmaceuticals Corporation (TLOG) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does TLOG update its statements?: TetraLogic Pharmaceuticals Corporation files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.